Benjamin Drew Davies - Jul 21, 2022 Form 4 Insider Report for NATUS MEDICAL INC (NTUS)

Role
Executive VP and CFO
Signature
/s/ DOUGLAS BALOG by POWER OF ATTORNEY
Stock symbol
NTUS
Transactions as of
Jul 21, 2022
Transactions value $
-$6,091,841
Form type
4
Date filed
7/21/2022, 05:10 PM
Previous filing
Jan 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTUS Common Stock, $0.001 par value per share Award $0 +106K +139.86% $0.00 182K Jul 21, 2022 Direct F1
transaction NTUS Common Stock, $0.001 par value per share Disposed to Issuer -$6.09M -182K -100% $33.50 0 Jul 21, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Benjamin Drew Davies is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock subject to performance-based stock unit awards that vested and were settled as a result of the merger ("Merger") pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc. ("Parent"), Prince Mergerco Inc, and Issuer ("Merger Agreement").
F2 Disposed of as a result of the Merger.
F3 Each share of Commons Stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to the applicable tax withholding.